Hepatitis C Virus Clearance with Sofosbuvir / Daclatasvir Regime Improves Oxidative Stress of Diabetic Status in HCV Patients by Regulating NF-κB / Nrf2 mRNA expression
Abd El-Hameed, A. (2022). Hepatitis C Virus Clearance with Sofosbuvir / Daclatasvir Regime Improves Oxidative Stress of Diabetic Status in HCV Patients by Regulating NF-κB / Nrf2 mRNA expression. EKB Journal Management System, 65(132), 1437-1447. doi: 10.21608/ejchem.2022.135231.5945
Abeer Mohamed Abd El-Hameed. "Hepatitis C Virus Clearance with Sofosbuvir / Daclatasvir Regime Improves Oxidative Stress of Diabetic Status in HCV Patients by Regulating NF-κB / Nrf2 mRNA expression". EKB Journal Management System, 65, 132, 2022, 1437-1447. doi: 10.21608/ejchem.2022.135231.5945
Abd El-Hameed, A. (2022). 'Hepatitis C Virus Clearance with Sofosbuvir / Daclatasvir Regime Improves Oxidative Stress of Diabetic Status in HCV Patients by Regulating NF-κB / Nrf2 mRNA expression', EKB Journal Management System, 65(132), pp. 1437-1447. doi: 10.21608/ejchem.2022.135231.5945
Abd El-Hameed, A. Hepatitis C Virus Clearance with Sofosbuvir / Daclatasvir Regime Improves Oxidative Stress of Diabetic Status in HCV Patients by Regulating NF-κB / Nrf2 mRNA expression. EKB Journal Management System, 2022; 65(132): 1437-1447. doi: 10.21608/ejchem.2022.135231.5945